The oncogenic transcription factor FOXM1 and anticancer therapy.
Comment on: Halasi M,et al. PLoS ONE 2012; 7:e31761.
Andrei L
AL
Gartel
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D045744:Cell Line, Tumor; D051858:Forkhead Transcription Factors / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism; D000090243:Nucleophosmin; D009857:Oncogenes / Q000235:genetics*; D011094:Polyethyleneimine / Q000737:chemistry; D061988:Proteasome Inhibitors / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000378:metabolism
D000970:Antineoplastic Agents; D051858:Forkhead Transcription Factors; D009687:Nuclear Proteins; D061988:Proteasome Inhibitors; D034741:RNA, Small Interfering; D000090243:Nucleophosmin; D011094:Polyethyleneimine